Description
Canine Adenovirus Type 2, Parainfluenza, Bordetella Bronchiseptica Vaccine, MODIFIED LIVE VIRUS, AVIRULENT LIVE CULTURE
Features and Benefits
- Protects against Bordetella, canine parainfluenza virus, and canine adenovirus type 2.
- ADT eliminates the possibility of accidental injection
- Offers the superior benefits of intranasal administration
-
- Can be used in puppies as young as 3 weeks of age because maternal antibodies do not interfere with localized antibody response
-
- Requires only single-nostril administration—low dose of 0.5 mL
-
- Provides rapid protection as early as 48 hours post-vaccination against B. bronchiseptica.1
-
- Provides 1-year duration of immunity for B. bronchiseptica.2
Indications
- Approved for the vaccination of healthy dogs as an aid in prevention of infectious disease associated with canine adenovirus type 2, canine parainfluenza virus, and Bordetella bronchiseptica infection
- Recommended for use in healthy dogs 3 weeks of age or older
Safety information
Administration and Dosage
- DESIGNED FOR INTRANASAL USE ONLY WITH THE ENCLOSED APPLICATORS
- Using supplied nasal applicator, instill 1 dose (0.5 mL) into one or both nostrils
- Annual revaccination with 1 dose is recommended
Reviews
There are no reviews yet.